pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-23a |
Genomic Coordinates | chr19: 13836587 - 13836659 |
Synonyms | MIRN23A, hsa-mir-23a, miRNA23A, MIR23A |
Description | Homo sapiens miR-23a stem-loop |
Comment | This miRNA was previously named miR-23 . This finding was later retracted after the discovery that the regulated gene was human homolog of ES1 (HES1), whose function is unknown. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-23a-5p | |||||||||
Sequence | 9| GGGGUUCCUGGGGAUGGGAUUU |30 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Cloned | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SSBP2 | ||||||||||||||||||||
Synonyms | HSPC116, SOSS-B2 | ||||||||||||||||||||
Description | single stranded DNA binding protein 2 | ||||||||||||||||||||
Transcript | NM_012446 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SSBP2 | |||||||||||||||||||||
3'UTR of SSBP2 (miRNA target sites are highlighted) |
>SSBP2|NM_012446|3'UTR 1 TCCATTACCAAGTCTCCTCATGAAAACCACAGTGAGTCAGCCCTTCACAGAACTACTACGGAAGAAAATTATTCATCACA 81 GTGTACAGTTAAACAAAGGAATCTCAGTCACACCAAACCAACCTTTTTATTTCCTGCTCTCTCCCCTCTTTTGTGAAGAA 161 AGCGGGTCCAAATGTGATTCAAACAACTGTACGGAGTGGCATATTAGAATTGCCCTAAACTGAACTGCAAATAATTATGT 241 GTGTATGTATATGTGTGGGAAAGAGAATGTACTGTATATGTGTATGTTATACAGACATATACACATACATACATTGACCC 321 ACAGGACATTGTAAAATATTATCACATGACATCTTAAGTAGAAATAAGTAGGGACTTTTATTCCATCCTTTTTTTCACGT 401 TTACATTTTAATTATTACAAGTTGCTCCTGCCCCCTCCCTGAACTATTTTGTGCTGTGTATATCACTGCTTTATATAAGT 481 TATTTTTTAAGGTGAACTCAGATGTTATGGTTTTGTAAATGTCTGCAATCATGGATAGGAATAAAATCGCTTATTTGAGA 561 GCTTTCATTAAATTGCGTCTGATGCAAGTTATCCTGTGAATCACAAAGTGTACTGTCTCAAAAAATAGAAGAAAATGTGT 641 CTTCGTCTTTATGTTGAATCAAACAATTTCTCAGTTACCTTCAGTGAAAAGTATTTTTTTAATTTTTATTTGAGAAAAAC 721 ACTTCAAATCAGTAAAAGCTTAACTGGGGCCTCACACAGTATATTTCTGCAATAACTGCTTTAAACGGAGTTCTTGATTT 801 GTTTGTCTTAGATGATACAGAAATCATTAAATAGCCCAAATCATTTAGACCATAGCAATAAAGTGACCGGGGTTGTCATA 881 TATTTAGCAACATCTTTTCTCTTTAACATGATGAAGCCCAAAAGTGATAACAAAAGCATTTGCTTGAATTTGTCACTTCT 961 CACCAGGAGTACTAGAGGTAAATTTTTAATAACATACTAATGTGAAATGGTATCTGGTTTTTATTCAGACTTTTTGTGAG 1041 CATATTCTTATAGACACTAGAAATAAATACATAGAAGGAGACTTTGAGCACAAGGGAGAAGAGAGTTATTAGCACTCCTG 1121 AGGCCTCTGGAATGCTGCTTTTCTATCCAGGTATCTTGCTTGCTACCAGCAGAATTGACTGGTATTGGTTCTCACTGGCC 1201 AGGGAGCCTCTGCTCTGTTCCTGGAATATAAGGCTTTTATTCAGGAGCAAATCATTGATAGTAACTTTGCTTTATCTAGC 1281 CATTGACTTCAGCAGGCTAAAACTACATTGTGTAACTGACTGTTCAAAAAAGAATAAGTAAATTTTTTTTAATCTAATTC 1361 CCTTATGGAAAGCACCTTGCTCTATGGCACTTTCCAGATCTTTTGGGATTTTGTGCTTAATTATACATACATACACCAAA 1441 ATCACAATAGAAAGATATGAAGACTTTAATTTTAGACTCTGAAAGATAACTGGGTGATCCTTTGTGTTAAAATTGTGATA 1521 CAAACAACCATTGATAAATACCAACTATGAATCCAAACTCTAGAGACTTTGAAAAGCATTGTTTAATTGCAGGTAAGAGG 1601 AATCTTCTCTTTCCTTTAGGCTTATAGTCTCTAAAGTGAAAATTTGGCAGGATATAGTCATGCAGCTCATAATGACATTC 1681 CAATCAACCACAGACTGCATATACAGCAGTGGTCCTATAAGATTATAATACCATATTTTTAGCATATCTTTTCTATGCTT 1761 AGATACACAAATACCATTGTATTACAGTTGCCTTTGGTATTCAGTACAGTAACATGCTGTACAGGTTTGTAGCCTAGGAG 1841 CAATAGTTTATATTATATAGCCTAGGTGTGTAGGAGCCTATACCATCTAGGTTTGTGTAAGTACACTCTATGATGTTCAG 1921 ACAAGGACAATATTGCCTGACAATGCATTTCTCAGAATGTATACTTATCATTAAGTAACATATGACTGTATGTACTAGTT 2001 CCTGATGACTTACTTCTCTCAAATTCATAATGATTTAGTCCTTGTAAAAATAAAGATTTTGCCTGTGCCTAAACAGGGAT 2081 ACTAGGCAGAACTGTTGAGAAAAAAAAGCTGAATTAAATTTATGTTGCAGATTTAAACTATCATAAAATGAGCCTCAGTT 2161 AATCACACACAGTATTCAGGTGCCTAGGAGTGCACACCGGAGAACAGCCTCATGCTGTCAAGCTGCAGAAACCTTTCATG 2241 CAAATTCAGATGAAAAGGTCTTTACCTCAAGCCAGGGTAACCTGAATGAAGGTGATAGTTTGTCCAGACACCTGACTTTA 2321 CCAAGAAGAATTTTGACTTTCATATTTTATGACAATCATATAAAAATTGACAGTCCTTTGATTATTAAGCTTAATCTTAT 2401 AATGCTAGAATTTTCAAATATTTTGTTGACTCTTCTCCATTGTTACCGATCTTGAAATTCTTTTCTTCGCCTTCTGAGAA 2481 GGTATTATTTCTTATCACAAAGAATGATGAATATGATTTTATCTACCCTTATTTTGGGGGTAATACGAGAATATGAATTG 2561 CATCATGATCCCCATTATTTCTAACCTAAAAGTAAAATTCGTTTTTTTTTTCAAGGCAGAGCAGTCAATTGATTATAAGT 2641 ATTTATTTCTTTTTTCTTCTTGGAGCCCAGATTAAAAAGAGTTATTTTAGATTTAAAAATTTCCTGAAATAGTTGAAAAA 2721 TTATTTTTGAGGAGAAAATTGTATCCAAGAAACCCAGAATGTAAGGATACTTGATTTTTATATCCAGATAATTCTTTCAT 2801 GCACTGAATGGAAGACAGTATATCTGTATATTAATTTTTGTTTAGATTTTGAATCATTTAACCCTTATCCTTTTTTCTTG 2881 TAATAAGACTATTTAATGTTTTTCTCTTGTGTTTTCCATCTTTATCAATGCATTCGTGTTGGTCTTGATGTATACTACCT 2961 GTTCCTAGTGTTATTTTTACACGTCATCTCACAGTAATAATATCAGCAATTCTTGCTGCATTGAACATATTAAATACACA 3041 TGTAAAATGAAAAAGTAAGCAGTAGGTAAAATCTTGTTACTCTGCTTTGCATTCTGCCTAACTCACTGCATTTGAAAATA 3121 CATGTCAAATTCTTTCTGAGGGTATGTATGATTCTTAACTACGTGTCTTACAGCAAAGTTGCCCATGGGAACAAAGGCTG 3201 TAGGGTGTCATTGATCTTGTAATACAACACATATTTGATGGGTGAATCTTATTAGCACTCCTTTGAAAATGTTCCAGTAT 3281 GGAGTCAGTTGCTGATAAAGAGGAAGTTCACAGCTAGGAATCCGAAGTTAAGATTTCTCAATTGCCGCCTGGGCACTCAT 3361 GCCTGTAATCCCAGCACTTGGGAGGCCAAGGTGGGCAGATCACCTGAGGTCGGGAGTTCAAGACCAGCCTGGCCAACCTG 3441 GTGAAACCCCCCCATCTCTACTAAAAATACAAAAATTAGCCAGGTATGGTGGTGGCTGCCTGTAATCCCAGCTACTCAAG 3521 AGGCTGAGGCGGGAGAATCACTTGAACCCAGGAGGCGGAGGTTGCAGTGAGCCGAGATTGTGCCACTGCACTCCAGCCTG 3601 GGTGACAGAGCAAGACTCCATCTCAAAAATAGAAAAGATTTCTCAATTGCCAAAAAGATTAACAAGTAAATCAATTCTGC 3681 TCCCCCAGCCATGAAAAGTGCCCAAAACAGCCCTTTCCCTCCAGAATAAAATAAAACTTCCATTTCTATTTTTATGATTC 3761 TCTAAGATATCTGAACTCCATTGCATTTCATAGGGTTATTCAGTTAGCACTTCTGTGGTTTAAAAGACAACAAATGAAAA 3841 TAAGTAAGTTCAGTTTGGGGCATGAAGAAGTCCCACATCTGTCTATATCTTTTCTTCATCATATTGTCCCTAGGAATGTA 3921 TAGCAAAGCATTCAGAACTGCTCCTTTGGCTGGGGAAGTTTTCCACCGTCCTTAATACTATGAAGTCTTGATTACTTCTT 4001 CCGTGGCTTTATCCTTGCCTCCCTCCCAATCCCTGCATCTTCCAGGAGAAATAAAATACCAACTGAACACTGTTACCTTC 4081 TCAGCCCTTACCATTTTCATCTGCATATAGTGTATAGTACTAAGAGTAGTTTTCCCAGGAGAAATAATTGCAATTTTCAT 4161 TTCTTGATTATCACTGCTAATTCGAAGGAGTGCCACAAATCATAGCCACTTGATTTTGATTTTGGAATGCATTTTAGTGT 4241 TTTGACACTGGTTTTCCTTTTTTTTAAATTTTTTTTTCTTTTTTTTTTTTGAGACAGTCTTGCTCTGTCACCCAGGCTGG 4321 AGTGCAGTGGCACAATCTTGGCTCACTGCCGTCTCCGCCTCCCAGGTTCCAGAGATTCTCCTGCCTCAGCCTCCAGAGTA 4401 GCTGGATTACAGGCATGCGTCACAGGCTAATTTTTGTATTTTTAGTAGAGGCAGGGTTTCACCATGTTGGCCAGGCTGGT 4481 CTGGAACTCCTGACCTCAAGTGATCTGCCCGCCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCCACTATGCTTG 4561 ATCAGGTTTTCCTCTTTTTTTTTTTTTTTTTTGAGTCAGAATCTTGCTCTGTCACCCAGGCTGGAGTGCAATGGTGTGAT 4641 CTCGGCTCACTGCAACCTTCACCTCCCGGGTTCATGCAATTCTCCTGCCTCAGCCTCCCGAGTGGCTGGGACTACAGGTG 4721 CTCACCACCATGCCCAGCTAATTTTTTGTATTTTTAGTAGAGACCGGGTTTCACCGTGTTAGCCAGGATGGTCTCGATCT 4801 CCTGACCTCGTGATCCACCCGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCATGAGCCACCGTACCTGGCCCAGGTTT 4881 TCCTTTTTTTTTATGTCTTCTGTACAATAGAGTTGGCCCTCCATATCCACAGGTTCCACATCCCTGATTCAATCAACTCC 4961 TGATAAAAAATATTGGAAAAAATTTTTATAACAATAAAAACCAATAATACAACAATAATTACAAATAATACATTGTAACA 5041 ATGATTTCCATGGCATTTATAATACATTGTATTAGGTATTATAAGTAAACGAGATGATTTGAAGTATATTGGAGGATGTG 5121 CATAGGTTATACTATGCCGTTTTATATAAAGGACTTAAGCGTCTGTGGATTTTGGTATCTGCAGAGGTCCTGGAACCGGT 5201 CTCCCTTGGATACGGAGGGACAACTGTAGTTCTCTGTCTTTGAAAACATTAATCGATACAAGTGGCCAGTGAATGTATAG 5281 TATGGGAGGGAGTAATCCAGTATGGGGGACAAGGTTGCCATATATTTGCCAAAAGTAGTTGAATCTTCTTTCTGTTTTTC 5361 CCTCCTGGTGGAATAAGTTTATTGTTTGCTATGAGGAGCCAGAGGCTGTGTTTGTTTAAAGCAATGGTACCCAATCTTAA 5441 GCATGTGTAAAGGTCTCCCTGGGTCTGTGAACCATACCTTGAGAAATAACTAGAAAAGTAAAAGAATGGTGAACCACTAT 5521 TAATAATACTTCCATTTTGCATACTAAATATGTTGCGTGTACCTGTGTGTGTGTGTTGGGAATAGTAATATGAAGTTTGC 5601 TCACAAAACACTCCCACTGTGATTCACATTATTTTATAGCACAACCAATAATGATTAAACATAATTATTTCCTTTGACTA 5681 CTTTTCATTTCAGTGGTAAAACAGCTGATGAAAGTTATTTGGGATGGAAAGAGTAATACAAGACATACGCAGATGGAGTC 5761 TCCTGTGCGTAGGTTTAGCACACCCATGTTAGCTTGTCCACATTAGGCCTTCTTTTGAAGGTACTGTATCTAAAGATAAG 5841 GGCATAAGTGATCATTTAATTCTCAGCCACTTCACTGATACTACAAGGTGTTACACAGTAATTATAGTGGTTTGATACAG 5921 ACATTTGTTTACAAGAAACTGAATTGGCATTATTAACTTATTTCACACAAAAAAAGTTAGCTTTACCCATGAACTGTAAT 6001 TCAGATTGATAAGGTGACCTACCCATGAAAAAGACACCTGAGACCTGTTTACTTTTTTAAACTATGAAGTGAAATCCTCA 6081 GTTCAATAAGTGTCCCAAGGAGAATTTCCTCTGTTAAATTTTCCCTGTTAACTTAGTATAATTGGTTTTCTTGAATAGAA 6161 GAATAATGATTTCTGTAAGATATTTTAATGTGAATATTTTTGCTGTCTTCATCTTTAAAAATTAAATACAGTACTATATA 6241 TAGATATTAAAATTTTAAAGTGGGACTAGGTGTTTTTATGTATACAATTACAGTTTGTCTCCTCTCTTTGCAAATTTACT 6321 GGCTATTATCAGAATAAAGGTTGGACTCATTTTGCTTATCCCAGTCATTAAAATGTTGTGATCTGTTTCTAACATATTTA 6401 GCATTTCATTTTTAAAATGAGATGTGCCATTATCATAACAAAGGCAACTATTAATGTTCCTAGAAAAAATGATGTAAAGG 6481 ACTTACTCCTAGTCAATATTAACACTTAATCCCACTTTCTTTTTTCCACCAAATGGCCTCAGTACATTGCCAAGAGAGTG 6561 AAATTTGGATTCCTCACAGTACTCAGAACACAATATGATATTTGTCAGCTAACTTTCCATCATGTCTTGGTAAAATTGCT 6641 CAGTTAAATATAATTGGCCATCTACTTATTAAAAAACAATTCAAATAATCTGTACAGTTACCATAATTTGACAACAAATT 6721 ACTTTAAATTTAGCACCATCTTAGAAATCTTCTTAATATAAACTACTGATTGAAATGTGTTTATACTTTCTATCATATTT 6801 CAAACTGTTTTACTTTCCTTGCATTAAGACAATTAAAACACAAACTACATGTTAGAATGAATAATTTAAAGGACATGCTG 6881 CTGTTTCAGCATAAAAAATGGTAAAGTCTTTATAAATAGAATACTTATGATAGCCATTAACGTATTGAATTGTTTAATTA 6961 ACCTAGTTGTGATTTTCCGAATTTAAGACGTTTTCTTACTACATGTGTTAAATTGTTACCTATAATATCTTCCTGGAAAA 7041 ATAGAAGTATTTGTAAGGTTTTTATAAATGCACAATTTATGTATAAATATAATTGGAATCTGGGATGACTCTTAGTAATC 7121 TACTATTCTTAATTCAACGATGGCCACCAGCTACCTGACACATTTTGTAAATTTAGCATCTGTGTATGTGTGTTCGTGTA 7201 TGTGTGTGTGCGTGCATGTGCACATTACTGCATTTATTCTCAAATGGATTTATAATTTAGTGTTTTTGTACAAGTACTTG 7281 AGCTATTCATGTAATGGGATAAGTTGCCATAAAGATGTACATAAATGACCCTTAATTTGGCACGTTTTCACATTTAATTT 7361 TTTAAAATACAGCTTTTCATATACAGTTCCTACCCTTTCATTTCTAGCCTGTACTTCATTACTTGTTGAAAAAGTCAAGT 7441 TTGTATGAAGCCAGCATAAACATCAAAATATAACTAATGTGGACATCTGTGTATATAATTGAATTAGACATTATGCCTTA 7521 TATAAAATTCAGGAGGTTCTAATATCAAAGGATCTATATGCATGGAAGAAGAGGCTACAATGCATATATCAATGGCTGGC 7601 TCTATGTGGTCAGATAACTAAACATGGAATGCCAAAAAAAAACTAATGTTATTAGCAAATAGATATGTTAATGAATTAAA 7681 CTTTGGTATTTTACTGC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084041. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep1
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084041 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep1 |
Location of target site | ENST00000320672.4 | 3UTR | GGGAGAAUCACUUGAACCCAGGAGGCGGAGGUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
131 hsa-miR-23a-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT038958 | ATF1 | activating transcription factor 1 | ![]() |
1 | 1 | |||||||
MIRT057661 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT395438 | NFKBID | NFKB inhibitor delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT463884 | WNT7B | Wnt family member 7B | ![]() |
![]() |
2 | 4 | ||||||
MIRT475804 | HDGF | heparin binding growth factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT478528 | CTNS | cystinosin, lysosomal cystine transporter | ![]() |
![]() |
2 | 2 | ||||||
MIRT479278 | CHD4 | chromodomain helicase DNA binding protein 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT492564 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | ![]() |
![]() |
2 | 2 | ||||||
MIRT500353 | ZNF385A | zinc finger protein 385A | ![]() |
![]() |
2 | 2 | ||||||
MIRT509788 | CHAF1B | chromatin assembly factor 1 subunit B | ![]() |
![]() |
2 | 4 | ||||||
MIRT511566 | HIST3H2BB | histone cluster 3 H2B family member b | ![]() |
![]() |
2 | 4 | ||||||
MIRT525450 | GPATCH2L | G-patch domain containing 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT539558 | CNKSR3 | CNKSR family member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT540034 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | ![]() |
![]() |
2 | 4 | ||||||
MIRT540225 | SAMD5 | sterile alpha motif domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540242 | RGS17 | regulator of G protein signaling 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540871 | ZBTB24 | zinc finger and BTB domain containing 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559065 | C19orf47 | chromosome 19 open reading frame 47 | ![]() |
![]() |
2 | 4 | ||||||
MIRT560685 | HIST1H1T | histone cluster 1 H1 family member t | ![]() |
![]() |
2 | 2 | ||||||
MIRT565593 | SLC35G1 | solute carrier family 35 member G1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565642 | SKI | SKI proto-oncogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT576747 | Tmem127 | transmembrane protein 127 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607712 | LIMS1 | LIM zinc finger domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615682 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617337 | ZSCAN2 | zinc finger and SCAN domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617378 | FAM227A | family with sequence similarity 227 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT620855 | SERPING1 | serpin family G member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625112 | SLC1A5 | solute carrier family 1 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625124 | NUP93 | nucleoporin 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625898 | LINC00632 | long intergenic non-protein coding RNA 632 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626016 | XRCC2 | X-ray repair cross complementing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626481 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626573 | MED7 | mediator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626814 | PRR11 | proline rich 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628136 | HM13 | histocompatibility minor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630771 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633133 | C6orf132 | chromosome 6 open reading frame 132 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636950 | APTX | aprataxin | ![]() |
![]() |
2 | 2 | ||||||
MIRT637802 | GGPS1 | geranylgeranyl diphosphate synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638622 | GSR | glutathione-disulfide reductase | ![]() |
![]() |
2 | 4 | ||||||
MIRT642196 | SMAGP | small cell adhesion glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT645121 | HES2 | hes family bHLH transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645344 | AGTPBP1 | ATP/GTP binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646564 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649243 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651810 | USP49 | ubiquitin specific peptidase 49 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652137 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652668 | TIMELESS | timeless circadian clock | ![]() |
![]() |
2 | 2 | ||||||
MIRT655894 | NEK9 | NIMA related kinase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656564 | LYRM7 | LYR motif containing 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657194 | IKZF3 | IKAROS family zinc finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657907 | GDE1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660207 | BMPR1A | bone morphogenetic protein receptor type 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT660619 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT660826 | AGO3 | argonaute 3, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT660986 | ABHD2 | abhydrolase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662232 | PGBD4 | piggyBac transposable element derived 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663691 | ZNF347 | zinc finger protein 347 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665577 | TUBD1 | tubulin delta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666149 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT666310 | SLC22A3 | solute carrier family 22 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666457 | SCRG1 | stimulator of chondrogenesis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667716 | KIAA1468 | KIAA1468 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668329 | FKBP5 | FK506 binding protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668370 | FBXO47 | F-box protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669304 | C17orf75 | chromosome 17 open reading frame 75 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669538 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT671681 | ADK | adenosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT672177 | MRE11A | MRE11 homolog, double strand break repair nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT673604 | HPSE | heparanase | ![]() |
![]() |
2 | 2 | ||||||
MIRT673749 | ZNF333 | zinc finger protein 333 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674807 | FAM229B | family with sequence similarity 229 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT675286 | ARL10 | ADP ribosylation factor like GTPase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675391 | SVOP | SV2 related protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT675788 | MED28 | mediator complex subunit 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676151 | OGFOD1 | 2-oxoglutarate and iron dependent oxygenase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676499 | GJD3 | gap junction protein delta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676621 | CSNK1E | casein kinase 1 epsilon | ![]() |
![]() |
2 | 2 | ||||||
MIRT676644 | GTDC1 | glycosyltransferase like domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676711 | METTL14 | methyltransferase like 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676809 | SHROOM4 | shroom family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677036 | FOXO3 | forkhead box O3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677062 | NT5C2 | 5'-nucleotidase, cytosolic II | ![]() |
![]() |
2 | 2 | ||||||
MIRT677086 | SMIM15 | small integral membrane protein 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677193 | MURC | caveolae associated protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677273 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT677345 | POC1A | POC1 centriolar protein A | ![]() |
![]() |
2 | 2 | ||||||
MIRT677504 | SLC10A6 | solute carrier family 10 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677526 | OCIAD2 | OCIA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677661 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677727 | SSR1 | signal sequence receptor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677803 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678144 | SLC4A4 | solute carrier family 4 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678376 | VTA1 | vesicle trafficking 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678708 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678868 | FAM118A | family with sequence similarity 118 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT679039 | LACTB | lactamase beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT679081 | PURB | purine rich element binding protein B | ![]() |
![]() |
2 | 2 | ||||||
MIRT679137 | SYK | spleen associated tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT679299 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679741 | CABP4 | calcium binding protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679946 | AS3MT | arsenite methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT679976 | E2F2 | E2F transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683628 | MTO1 | mitochondrial tRNA translation optimization 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683901 | PSMB9 | proteasome subunit beta 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684172 | MOG | myelin oligodendrocyte glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT684231 | C20orf144 | chromosome 20 open reading frame 144 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685403 | C1orf158 | chromosome 1 open reading frame 158 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686253 | ZBTB8B | zinc finger and BTB domain containing 8B | ![]() |
![]() |
2 | 2 | ||||||
MIRT687513 | NCKAP1 | NCK associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688243 | FITM2 | fat storage inducing transmembrane protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688315 | FAM151B | family with sequence similarity 151 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT688733 | CNDP1 | carnosine dipeptidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689031 | ANGPTL3 | angiopoietin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698207 | TMEM248 | transmembrane protein 248 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699859 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT709954 | TRUB2 | TruB pseudouridine synthase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711541 | MSH3 | mutS homolog 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712077 | WDR37 | WD repeat domain 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715312 | POLR2E | RNA polymerase II subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT715725 | PIAS2 | protein inhibitor of activated STAT 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715748 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT717604 | DSTYK | dual serine/threonine and tyrosine protein kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT717875 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718042 | NIPAL2 | NIPA like domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718829 | CDT1 | chromatin licensing and DNA replication factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724037 | CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT733305 | TNF | tumor necrosis factor | ![]() |
1 | 0 | |||||||
MIRT734941 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737343 | IGF2 | insulin like growth factor 2 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737546 | PTEN | phosphatase and tensin homolog | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|